BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 7527672)

  • 1. Kit ligand/mast cell growth factor-independent differentiation of mast cells in myelodysplasia and chronic myeloid leukemic blast crisis.
    Valent P; Spanblöchl E; Bankl HC; Sperr WR; Marosi C; Pirc-Danoewinata H; Virgolini I; Eichler HG; Agis H; Sillaber C
    Blood; 1994 Dec; 84(12):4322-32. PubMed ID: 7527672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of mast cell growth factor (c-kit ligand) on clonogenic leukemic precursor cells.
    Goselink HM; Williams DE; Fibbe WE; Wessels HW; Beverstock GC; Willemze R; Falkenburg JH
    Blood; 1992 Aug; 80(3):750-7. PubMed ID: 1638026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of tryptase-positive KU812 cells cultured in the presence of Steel factor.
    Saito H; Miura K; Takahashi G; Ebisawa M; Matsumoto K; Shichijo M; Onda T; Iikura Y; Yanagihara Y; Ra C
    Int Arch Allergy Immunol; 1995; 107(1-3):330-2. PubMed ID: 7542083
    [No Abstract]   [Full Text] [Related]  

  • 4. Mast cells cultured from the peripheral blood of normal donors and patients with mastocytosis originate from a CD34+/Fc epsilon RI- cell population.
    Rottem M; Okada T; Goff JP; Metcalfe DD
    Blood; 1994 Oct; 84(8):2489-96. PubMed ID: 7522630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myelomastocytic overlap syndromes: biology, criteria, and relationship to mastocytosis.
    Valent P; Sperr WR; Samorapoompichit P; Geissler K; Lechner K; Horny HP; Bennett JM
    Leuk Res; 2001 Jul; 25(7):595-602. PubMed ID: 11377685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of malignant mastocytosis with circulating mast cell precursors: biologic and phenotypic characterization of the malignant clone.
    Baghestanian M; Bankl Hc; Sillaber C; Beil WJ; Radaszkiewicz T; Füreder W; Preiser J; Vesely M; Schernthaner G; Lechner K; Valent P
    Leukemia; 1996 Jan; 10(1):159-66. PubMed ID: 8558922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mast cell growth factor (c-kit ligand) restores growth of multipotent progenitors in myelodysplastic syndrome.
    Glinsmann-Gibson B; Spier C; Baier M; Taetle R; Broudy VC; List AF
    Leukemia; 1994 May; 8(5):827-32. PubMed ID: 7514248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of mast cell growth factor on acute myeloid leukemia cells in vitro: effects of combinations with other cytokines.
    Budel LM; Delwel R; van Buitenen C; Hoogerbrugge H; Löwenberg B
    Leukemia; 1993 Mar; 7(3):426-34. PubMed ID: 7680401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of mast cell growth factor on clonogenic blast cell growth in acute myelogenous leukemia.
    Siitonen T; Lundström M; Zheng A; Savolainen ER; Koistinen P
    Ann Hematol; 1996 Aug; 73(2):71-8. PubMed ID: 8774615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monocytes do not make mast cells when cultured in the presence of SCF. Characterization of the circulating mast cell progenitor as a c-kit+, CD34+, Ly-, CD14-, CD17-, colony-forming cell.
    Agis H; Willheim M; Sperr WR; Wilfing A; Krömer E; Kabrna E; Spanblöchl E; Strobl H; Geissler K; Spittler A; Boltz-Nitulescu G; Majdic O; Lechner K; Valent P
    J Immunol; 1993 Oct; 151(8):4221-7. PubMed ID: 7691941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant human stem cell factor stimulates differentiation of mast cells from dispersed human fetal liver cells.
    Irani AM; Nilsson G; Miettinen U; Craig SS; Ashman LK; Ishizaka T; Zsebo KM; Schwartz LB
    Blood; 1992 Dec; 80(12):3009-21. PubMed ID: 1281684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the c-kit proto-oncogene in myeloproliferative disorders and myelodysplastic syndromes.
    Siitonen T; Savolainen ER; Koistinen P
    Leukemia; 1994 Apr; 8(4):631-7. PubMed ID: 7512174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein kinase C-dependent release of a functional whole extracellular domain of the mast cell growth factor (MGF) receptor by MGF-dependent human myeloid cells.
    Brizzi MF; Blechman JM; Cavalloni G; Givol D; Yarden Y; Pegoraro L
    Oncogene; 1994 Jun; 9(6):1583-9. PubMed ID: 7514283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis of mastocytosis: general histopathological aspects, morphological criteria, and immunohistochemical findings.
    Horny HP; Valent P
    Leuk Res; 2001 Jul; 25(7):543-51. PubMed ID: 11377679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of mast cell growth factor on Ara-C mediated acute myeloid leukemia cell killing.
    Tafuri A; De Felice L; Mascolo MG; Valentini T; Petrucci MT; Petti MC
    Stem Cells; 1993 Jul; 11 Suppl 2():88-92. PubMed ID: 7691332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperfibrinolysis in a case of myelodysplastic syndrome with leukemic spread of mast cells.
    Wimazal F; Sperr WR; Horny HP; Carroll V; Binder BR; Fonatsch C; Walchshofer S; Födinger M; Schwarzinger I; Samorapoompichit P; Chott A; Dvorak AM; Lechner K; Valent P
    Am J Hematol; 1999 May; 61(1):66-77. PubMed ID: 10331514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The KIT and PDGFRA switch-control inhibitor DCC-2618 blocks growth and survival of multiple neoplastic cell types in advanced mastocytosis.
    Schneeweiss M; Peter B; Bibi S; Eisenwort G; Smiljkovic D; Blatt K; Jawhar M; Berger D; Stefanzl G; Herndlhofer S; Greiner G; Hoermann G; Hadzijusufovic E; Gleixner KV; Bettelheim P; Geissler K; Sperr WR; Reiter A; Arock M; Valent P
    Haematologica; 2018 May; 103(5):799-809. PubMed ID: 29439183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tryptase a novel biochemical marker of acute myeloid leukemia.
    Sperr WR; Hauswirth AW; Valent P
    Leuk Lymphoma; 2002 Dec; 43(12):2257-61. PubMed ID: 12613510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The human cardiac mast cell: localization, isolation, phenotype, and functional characterization.
    Sperr WR; Bankl HC; Mundigler G; Klappacher G; Grossschmidt K; Agis H; Simon P; Laufer P; Imhof M; Radaszkiewicz T; Glogar D; Lechner K; Valent P
    Blood; 1994 Dec; 84(11):3876-84. PubMed ID: 7524750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-4 inhibits the expression of Kit and tryptase during stem cell factor-dependent development of human mast cells from fetal liver cells.
    Nilsson G; Miettinen U; Ishizaka T; Ashman LK; Irani AM; Schwartz LB
    Blood; 1994 Sep; 84(5):1519-27. PubMed ID: 7520776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.